Beam Therapeutics Inc

2026-09-01 19:36; UTC

Beam Therapeutics appointed Eric Foster as chief commercial officer. Shares are trading lower despite the leadership change amid preparations for a 2027 product launch.

2026-08-31 19:16; UTC

Beam Therapeutics Inc. shares are trading roughly flat, with no specific news identified. The stock remains above its 20-day moving average.

2026-08-28 23:06; UTC

Beam Therapeutics Inc. shares are higher in after-market trading, advancing since Friday's close and positioned above its 20-day moving average.

2026-08-27 23:02; UTC

Beam Therapeutics Inc. shares are roughly flat in after-market hours with no specific news identified. The stock remains above its 20-day moving average.

2026-08-26 23:51; UTC

Beam Therapeutics Inc shares are higher in after-market hours, reflecting a broadly positive market trend. The stock is near the upper end of its one-month range.

2026-08-25 20:07; UTC

HC Wainwright reiterated its Buy rating on Beam Therapeutics, maintaining a $80 price target. Shares are gaining amid positive sentiment and elevated call activity.

2026-08-24 20:06; UTC

Beam Therapeutics Inc shares are lower today amid rising oil prices and geopolitical tensions, with no specific news identified to explain the decline.

2026-08-21 23:31; UTC

Beam Therapeutics Inc. shares gained in after-market trading, reflecting broader market recovery as traders engaged in bargain hunting following a recent downturn.

2026-08-20 22:16; UTC

Beam Therapeutics Inc. shares advanced in after-market trading, remaining above the 20-day moving average and near the upper end of their one-month range.

2026-08-19 23:06; UTC

Beam Therapeutics Inc. shares are higher in after-market trading, remaining above the 20-day moving average and near the upper end of their one-month range.

2026-08-18 19:16; UTC

Shares of Beam Therapeutics are lower today, having declined since Monday amid broader small-cap losses and rising U.S. Treasury yields.

2026-08-14 19:36; UTC

Beam Therapeutics is trading higher during Friday's session, recovering from an earlier dip. No specific news has been identified to explain the price action.

2026-08-13 23:01; UTC

Beam Therapeutics Inc. shares are higher in after-market trading, reflecting notable upward momentum since Thursday's close, despite no specific news identified.

2026-08-12 20:06; UTC

Beam Therapeutics Inc. shares are lower today, continuing a trend of declines since Tuesday's close amid broader market uncertainties and lower U.S. Treasury yields.

2026-08-11 23:06; UTC

Beam Therapeutics shares are higher in after-market trading, following a session peak. No specific news was identified to explain the price movement.

2026-08-05 19:52; UTC

Beam Therapeutics Inc is trading lower as broader market sentiment weakens. The decline follows disappointing ADP employment data, which missed expectations significantly.

2026-08-04 23:06; UTC

Beam Therapeutics Inc. shares are lower in after-market hours, following a session low shortly after the open, despite three consecutive higher daily closes.

2026-08-03 19:16; UTC

Beam Therapeutics is rising amid a broader market rally, with a market cap of $2.64 billion and $1.2 billion in liquidity to support operations.

2026-07-31 19:16; UTC

Beam Therapeutics shares are lower, reflecting a decline in first-quarter results and broader sector weakness. The stock remains near the lower end of its one-month range.

2026-07-30 23:06; UTC

Beam Therapeutics Inc shares are higher in after-hours trading, advancing since Thursday's close, despite remaining below the 20-day moving average.

2026-07-29 22:51; UTC

Beam Therapeutics shares are lower in after-market hours following a volatile session, amid broader market uncertainty after the Federal Reserve's interest rate decision.

2026-07-28 23:51; UTC

Beam Therapeutics Inc shares are lower in after-market trading, experiencing unusual volatility amid broader market declines and positioned below its 20-day moving average.

2026-07-27 23:06; UTC

Beam Therapeutics Inc shares are higher in after-market hours, despite a broader decline in trading. No specific news was identified to explain the increase.

2026-07-24 19:26; UTC

Beam Therapeutics is declining today, reflecting broader market trends, with the Russell 2000 Index down. The stock remains below its 20-day moving average.

2026-07-23 09:51; UTC

Beam Therapeutics is higher in pre-market trading, driven by significant upcoming clinical milestones, including the global BEAM-302 trial and an FDA application for risto-cel.

2026-07-22 23:46; UTC

Beam Therapeutics shares higher in after-market trading, advancing since Wednesday's close. The stock remains below its 20-day moving average amid broader market influences.

2026-07-21 18:06; UTC

Beam Therapeutics shares are higher today, reflecting positive sentiment in small-cap stocks amid anticipation of upcoming earnings results from major companies.

2026-07-20 23:56; UTC

Beam Therapeutics Inc is higher in after-market trading, showing notable strength since Monday's close. No specific news was identified to explain the movement.